This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
News|Slideshows|April 15, 2024
In This Issue: Total Pharmacy April 2024
Author(s)Lauren Massaro
See what's trending in pharmacy with a preview of the Total Pharmacy April issue.
Advertisement
The April 2024 issue of Total Pharmacy highlights the opioid epidemic as a significant public health concern, as well as the measures pharmacists can take to combat it. One of these measures includes communicating with patients to reduce the stigma surrounding substance use disorder; a further story provides complementary strategies that pharmacists can implement to improve patient communication and education. Check out other top stories here.
To read these stories and more,
Advertisement
Related to this article
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
Advertisement
Advertisement